Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
暂无分享,去创建一个
T. Wilt | G. Schectman | M. Iwane | H. Rubins
[1] G. Rosenhamer,et al. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. , 2009, Acta medica Scandinavica.
[2] D. Sackett,et al. The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.
[3] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[4] G. Ginsburg,et al. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels. , 1991, The American journal of cardiology.
[5] D. Salem,et al. Prevalence of risk factors in men with premature coronary artery disease. , 1991, The American journal of cardiology.
[6] J J Albers,et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.
[7] B. Rifkind,et al. The value of lowering cholesterol after myocardial infarction. , 1990, The New England journal of medicine.
[8] C. Glueck,et al. Lack of concordance in classification of coronary heart disease risk: high-risk HDL cholesterol less than 35 mg/dl in subjects with desirable total serum cholesterol, less than 200 mg/dl. , 1990, The Journal of laboratory and clinical medicine.
[9] J Pekkanen,et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.
[10] J. Ordovás,et al. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a). , 1990, The American journal of cardiology.
[11] M. Austin,et al. Plasma triglyceride levels and coronary disease. , 1989, The New England journal of medicine.
[12] D. Levy,et al. Cardiovascular risk factors in the elderly. , 1989, The American journal of cardiology.
[13] S. Grundy,et al. The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program. , 1989, Archives of internal medicine.
[14] P. Wilson,et al. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. , 1988, Arteriosclerosis.
[15] J. Huttunen,et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. , 1988, JAMA.
[16] W. Browner,et al. Risk factor modification after myocardial infarction. , 1988, Annals of internal medicine.
[17] S. Grundy,et al. Hypertriglyceridemia: Causes and Relation to Coronary Heart Disease , 1988, Seminars in thrombosis and hemostasis.
[18] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[19] H. Wolinsky. The effects of beta‐adrenergic blocking agents on blood lipid levels , 1987, Clinical cardiology.
[20] D H Blankenhorn,et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.
[21] J. Verter,et al. Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study. , 1987, American heart journal.
[22] P. Schwandt,et al. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: A controlled long‐term comparative trial , 1987, Clinical cardiology.
[23] D. Gordon,et al. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. , 1986, Circulation.
[24] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[25] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[26] W. Kannel. Nutritional Contributors to Cardiovascular Disease in the Elderly , 1986, Journal of the American Geriatrics Society.
[27] U. Goldbourt,et al. Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. , 1985, British medical journal.
[28] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[29] L. Wilkins. Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE , 1979, Circulation.
[30] J. Medalie,et al. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.
[31] N. Miller,et al. THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.
[32] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[33] D. Gordon,et al. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. , 1993, The American journal of cardiology.
[34] L. Mead,et al. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. , 1990, The American journal of cardiology.
[35] Daniel Steinberg,et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.
[36] W. Kannel,et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.